Notably, treatment with the lactate production inhibitor oxamate reduces tumor-infiltrating Treg cells by suppressing CCR8 expression, thereby enhancing CAR-T cell activation within the tumor microenvironment [165]. Here, CCR8 is linked to neoplasm.